Skip to main content
Year archive

SYNTARA LIMITED — 2025 filings

All 88 regulatory filings released by SYNTARA LIMITED (SNT) in 2025, sourced directly from the official regulator.

88 Filings
2025 Period
2025 filings (88)
Filing Released Lang
Letter to Shareholders 3 pages 294.6KB
Management Reports
2025-12-22 English
Amsulostat data to be presented at ASH 2 pages 145.5KB
Investor Presentation
2025-12-04 English
Skin scarring program to progress on positive Phase1a result 5 pages 205.0KB
Capital/Financing Update
2025-11-25 English
Notification regarding unquoted securities - SNT 6 pages 19.4KB
Share Issue/Capital Change
2025-11-25 English
Notification regarding unquoted securities - SNT 6 pages 19.4KB
Share Issue/Capital Change
2025-11-25 English
Notification regarding unquoted securities - SNT 7 pages 21.6KB
Share Issue/Capital Change
2025-11-25 English
Change of Director's Interest Notice - KM 2 pages 279.0KB
Director's Dealing
2025-11-25 English
Change of Director's Interest Notice - GP 2 pages 322.3KB
Director's Dealing
2025-11-25 English
SNT 9465 Webinar 32 pages 3.4MB
Investor Presentation
2025-11-25 English
Topical Pan-Lox Inhibition for Skin Scarring KOL webinar 3 pages 198.0KB
Regulatory Filings
2025-11-23 English
Initiation of amsulostat Phase 2 MESSAGE trial in MDS 4 pages 173.9KB
Regulatory Filings
2025-11-20 English
Chair's Address to Shareholders 2 pages 157.6KB
AGM Information
2025-11-19 English
CEO Address to AGM and Shareholder Resolutions 37 pages 1.7MB
AGM Information
2025-11-19 English
Results of AGM 2 pages 162.7KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-19 English
Positive opinion for Orphan Drug Designation in EU 2 pages 136.3KB
Regulatory Filings
2025-11-16 English
Quarterly Shareholder Report and Appendix 4C 11 pages 478.3KB
Interim / Quarterly Report
2025-10-27 English
Notice of Annual General Meeting/Proxy Form 26 pages 1.2MB
AGM Information
2025-10-19 English
Investor Presentation HK Ignite Investment Summit 17 pages 1.2MB
Investor Presentation
2025-10-14 English
Notification regarding unquoted securities - SNT 6 pages 19.5KB
Share Issue/Capital Change
2025-10-01 English
Notice under ASX Listing Rule 3.13.1 1 page 107.8KB
AGM Information
2025-09-30 English
Appoints global myelofibrosis experts to support amsulostat 2 pages 146.5KB
Board/Management Information
2025-09-29 English
Positive top-line Phase 2a data confirms competitive profile 5 pages 267.0KB
Capital/Financing Update
2025-09-29 English
Positive final Phase 2a amsulostat data webinar presentation 18 pages 1.6MB
Investor Presentation
2025-09-29 English
Receives A$5.6m R&D Tax Incentive 2 pages 143.4KB
Capital/Financing Update
2025-09-23 English
Investor Presentation E&P Small Cap Healthcare Conference 18 pages 1.3MB
Investor Presentation
2025-09-08 English
Letter to shareholders - path forward for amsulostat 3 pages 208.7KB
Regulatory Filings
2025-08-31 English
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change
2025-08-27 English
Preliminary Final Report 58 pages 3.9MB
Annual Report
2025-08-27 English
Annual Report to shareholders 56 pages 3.9MB
Annual Report
2025-08-27 English
Appendix 4G Key to Disclosures 14 pages 427.6KB
Regulatory Filings
2025-08-27 English
2025 Corporate Governance Statement 19 pages 295.3KB
Governance Information
2025-08-27 English
TechKnow Investor Presentation 19 pages 1.2MB
Investor Presentation
2025-08-18 English
Guidance from FDA on amsulostat clinical progression 2 pages 183.6KB
Regulatory Filings
2025-08-10 English
FDA guidance webinar 2 pages 122.0KB
Regulatory Filings
2025-08-10 English
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change
2025-08-07 English
Notification regarding unquoted securities - SNT 7 pages 20.8KB
Share Issue/Capital Change
2025-08-03 English
Proposed issue of securities to the CEO 2 pages 132.2KB
Capital/Financing Update
2025-08-03 English
Reinstatement to Quotation 1 page 90.6KB
Regulatory Filings
2025-08-03 English
Quarterly Appendix 4C Cash Flow Report 5 pages 230.1KB
Interim / Quarterly Report
2025-07-31 English
Appendix 4C quarterly webinar 2 pages 143.9KB
Regulatory Filings
2025-07-31 English
Quarterly update webinar presentation 7 pages 455.5KB
Interim / Quarterly Report
2025-07-31 English
Quarterly Shareholder Report 5 pages 260.9KB
Interim / Quarterly Report
2025-07-29 English
Application for quotation of securities - SNT 6 pages 18.8KB
Share Issue/Capital Change
2025-07-29 English
First participant dosed in SNT-9465 Phase 1a/b trial 3 pages 201.1KB
Regulatory Filings
2025-07-28 English
Initiation of Phase 1b/2 AZALOX clinical trial of amsulostat 3 pages 195.9KB
Regulatory Filings
2025-07-17 English
First patient dosed in SATELLITE Phase 1c for keloid scars 4 pages 225.5KB
Regulatory Filings
2025-07-14 English
WHO grants official INN for SNT-5505 - amsulostat 2 pages 144.0KB
Regulatory Filings
2025-07-07 English
Notification regarding unquoted securities - SNT 6 pages 19.5KB
Share Issue/Capital Change
2025-07-01 English
Proposed issue of securities to the CEO 2 pages 107.3KB
Share Issue/Capital Change
2025-07-01 English
Application for quotation of securities - SNT 6 pages 18.8KB
Share Issue/Capital Change
2025-06-30 English
Ceasing to be a substantial holder 2 pages 123.6KB
Major Shareholding Notification
2025-06-22 English
Application for quotation of securities - SNT 6 pages 18.8KB
Share Issue/Capital Change
2025-06-15 English
SNT-5505 interim Phase 2 data webinar 2 pages 165.6KB
Regulatory Filings
2025-06-12 English
New positive interim data in Phase 2 study of SNT-5505 5 pages 258.3KB
Capital/Financing Update
2025-06-12 English
EHA 2025 SNT-5505 Interim Data Webinar Presentation 21 pages 5.4MB
Interim / Quarterly Report
2025-06-12 English
SNT-5505 awarded US FDA Fast Track designation 3 pages 212.1KB
Regulatory Filings
2025-06-09 English
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change
2025-06-09 English
Change in substantial holding 6 pages 620.8KB
Regulatory Filings
2025-05-25 English
Change in substantial holding 5 pages 200.9KB
Regulatory Filings
2025-05-21 English
Investor Presentation 24 pages 1.3MB
Investor Presentation
2025-05-06 English
March Quarter Shareholder Update Presentation 11 pages 652.4KB
Interim / Quarterly Report
2025-04-30 English
Quarterly Appendix 4C Cash Flow Report 5 pages 230.7KB
Interim / Quarterly Report
2025-04-29 English
Quarterly Activities Report 5 pages 243.6KB
Interim / Quarterly Report
2025-04-29 English
Appendix 4C quarterly webinar 2 pages 192.7KB
Investor Presentation
2025-04-29 English
Updated SNT-5505 study data to be presented at EHA2025 2 pages 179.3KB
Regulatory Filings
2025-04-28 English
Change in substantial holding 4 pages 188.8KB
Regulatory Filings
2025-04-23 English
Change in substantial holding 6 pages 254.0KB
Regulatory Filings
2025-03-30 English
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change
2025-03-27 English
Notification of cessation of securities - SNT 4 pages 14.8KB
Share Issue/Capital Change
2025-03-27 English
Change in substantial holding 3 pages 167.9KB
Major Shareholding Notification
2025-03-23 English
Acceleration of skin scarring program 4 pages 246.0KB
Capital/Financing Update
2025-03-17 English
Skin scarring webinar featuring Professor Fiona Wood 2 pages 192.7KB
Regulatory Filings
2025-03-17 English
Change of Director's Interest Notice - HDS 3 pages 282.1KB
Director's Dealing
2025-03-13 English
Syntara to present at NWR Virtual Healthcare Conference 2 pages 191.8KB
Investor Presentation
2025-03-13 English
Half Year Report and Appendix 4D 26 pages 2.0MB
Interim / Quarterly Report
2025-02-25 English
Change in substantial holding 6 pages 552.2KB
Regulatory Filings
2025-02-24 English
Notification regarding unquoted securities - SNT 6 pages 20.3KB
Share Issue/Capital Change
2025-02-24 English
Application for quotation of securities - SNT 6 pages 18.2KB
Share Issue/Capital Change
2025-02-19 English
Section 708A(5)(e) notice 1 page 148.4KB
Capital/Financing Update
2025-02-19 English
SNT drug leads to significant normalisation of skin scarring 3 pages 596.2KB
Regulatory Filings
2025-02-17 English
Chair's Address to Shareholders 13 pages 290.7KB
Declaration of Voting Results & Voting Rights Announcements
2025-02-16 English
Results of Meeting 2 pages 176.2KB
Declaration of Voting Results & Voting Rights Announcements
2025-02-16 English
Company Secretary Appointment/Resignation 2 pages 498.3KB
Board/Management Information
2025-02-05 English
Investor Presentation Euroz Hartleys Healthcare Forum 22 pages 1.8MB
Investor Presentation
2025-02-03 English
Quarterly Appendix 4C Cash Flow Report 5 pages 757.7KB
Interim / Quarterly Report
2025-01-28 English
Quarterly Shareholder Report 5 pages 239.7KB
Interim / Quarterly Report
2025-01-28 English
Application for quotation of securities - SNT 6 pages 18.8KB
Share Issue/Capital Change
2025-01-21 English
Notice of General Meeting/Proxy Form 21 pages 486.6KB
Proxy Solicitation & Information Statement
2025-01-16 English